Disclosure Of Material Accounting Policy Information [Text Block]

Innate Pharma - Filing #5981200

Concept	2024-01-01 to 2024-12-31
Disclosure of material accounting policy information [text block]
Description of accounting policy for depreciation expense [text block]
Description of accounting policy for determining components of cash and cash equivalents [text block]
Description of accounting policy for fair value measurement [text block]
Description of accounting policy for financial assets [text block]
Description of accounting policy for financial instruments at fair value through profit or loss [text block]
Description of accounting policy for financial liabilities [text block]
Description of accounting policy for foreign currency translation [text block]
Description of accounting policy for impairment of financial assets [text block]
Description of accounting policy for income tax [text block]
Description of accounting policy for issued capital [text block]
Description of accounting policy for leases [text block]
Description of accounting policy for intangible assets other than goodwill [text block]
Description of accounting policy for provisions [text block]
Description of accounting policy for research and development expense [text block]
Description of accounting policy for segment reporting [text block]
Description of accounting policy for share-based payment transactions [text block]